Abstract:Endometriosis is an estrogen-dependent gynecologic disease, which is characterized by the elevated ratio of ERβ/ERα expression. Retrograde menstruation leads to ectopic erythrocytes deposition and iron overload at pelvic cavity in endometriosis. Lipocalin 2 (LCN2) is a secretory protein that plays important role during iron transport and metabolism. To date, the relationship of estrogen and iron homeostasis is not well studied yet. The aim of our study was to investigate the role of estrogen in regulating iron metabolism in endometriosis. Sixty-eight women with endometriosis and forty-three women without endometriosis (controls) were included, and their serum levels of estrodiol and LCN2 were determined for via ELISA. Primary cultures of ESCs were obtained in vitro. The expression of estrogen receptor (ER) α, ERβ, and LCN2 was examined by qPCR, western blot, and ELISA. ChIP was used to investigate how ER regulated LCN2. Cell viability was assessed by Cell Counting Kit-8 assay. Reactive oxygen species production was evaluated by dihydroethidium staining. In addition, the intracellular ferrous iron level (Fe2+ ) were examined using an iron assay kit. Ferroptosis was evaluated by Cyclooxygenase-2(COX-2), Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4), glutathione peroxidase 4 (GPX4) and ferritin heavy chain 1(FTH1). Elevated serum LCN2 levels were found in women with endometriosis compared to those without. A positive correlation of E2 and LCN2 was observed in endometriosis group but not in controls. E2 dose-dependently increased the LCN2 expression in ESCs. This was also seen in the presence of ERα antagonist alone but not with ERβ antagonist alone. Interestingly, ERα bind to LCN2 promoter and attenuated the expression of LCN2. Moreover, E2-induced LCN2 expression resulted increased intracellular iron concentrations. Importantly, LCN2 attenuated GPX4 and FTH1 expression, increased COX-2 and ACSL4 levels, which in turn inhibited the ferroptosis of ESCs. This ferroptosis inhibition effect can also be partly reversed by the inhibition of ERβ or overexpression of ERα. Our studies demonstrate that upregulated E2 may inhibit ferroptosis via ERβ/ERα/ LCN2 pathway, potentially resulted in endometriotic tissue survival and progression, ERβ/ERα/LCN pathway may be a potential target for endometriosis treatment.

Resveratrol protected against the development of endometriosis by promoting ferroptosis through miR-21-3p/p53/SLC7A11 signaling pathway

Transcriptome-Based Analysis Reveals Therapeutic Effects of Resveratrol on Endometriosis in Arat Model.

Abstract #1504468: Estrogen Attenuates Ferroptosis Via Estrogen Receptor (ER) Β/erα/lipocalin 2 Pathway in Endometriosis

Macrophages originated IL-33/ST2 inhibits ferroptosis in endometriosis via the ATF3/SLC7A11 axis

The Lipid-related Effects of Resveratrol on Human Ectopic Endometrial Stromal Cells and a Rat Model of Endometriosis

Lipidomic Alterations and PPAR α Activation Induced by Resveratrol Lead to Reduction in Lesion Size in Endometriosis Models

Lipidomic Alterations and PPARα Activation Induced by Resveratrol Lead to Reduction in Lesion Size in Endometriosis Models

PDLIM3 knockdown promotes ferroptosis in endometriosis progression via inducing Gli1 degradation and blocking Hedgehog signaling pathway

Repression of FBXW7 by HES5 contributes to inactivation of the TGF-β signaling pathway and alleviation of endometriosis.

Iron overload increases the sensitivity of endometriosis stromal cells to ferroptosis via a PRC2-independent function of EZH2

Exosomal Mir-22-3p Derived from Peritoneal Macrophages Enhances Proliferation, Migration, and Invasion of Ectopic Endometrial Stromal Cells Through Regulation of the SIRT1/NF-κB Signaling Pathway

Effect and mechanism of resveratrol on ferroptosis mediated by p53/SLC7A11 in oral squamous cell carcinoma

Resveratrol mediates the miR-149/HMGB1 axis and regulates the ferroptosis pathway to protect myocardium in endotoxemia mice

SCM-198 Prevents Endometriosis by Reversing Low Autophagy of Endometrial Stromal Cell via Balancing ERα and PR Signals

SOX4 inhibits ferroptosis and promotes proliferation of endometrial cancer cells via the p53/SLC7A11 signaling

SCM-198 Prevents Endometriosis by Reversing Low Autophagy of Endometrial Stromal Cell <i>via</i> Balancing ERa and PR Signals

SCM-198 Prevents Endometriosis By Reversing Low Autophagy Levels Of Endometriotic Stromal Cells Via Inhibiting TNF-Α-Aromatase-Estrogen-Erα Pathway And Promoting PR Expression

SCM-198 Alleviates Endometriosis by Suppressing Estrogen-ERα Mediated Differentiation and Function of CD4+CD25+ Regulatory T Cells

Endometrial Stem Cells Alleviate Cisplatin-Induced Ferroptosis of Granulosa Cells by Regulating Nrf2 Expression

Long noncoding RNA ADAMTS9-AS1 represses ferroptosis of endometrial stromal cells by regulating the miR-6516-5p/GPX4 axis in endometriosis

Cell Membrane Camouflaged and ROS Responsive Nanosomes for Targeted Endometriosis Therapy Via Reversing Inflammatory, Low-Autophagy, and Immunotolerant Microenvironment